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Review Article
Perfusion imaging in ischaemic stroke
Zafar Sajjad
Department of Radiology, Aga Khan University Hospital, Karachi. Pakistan. 
Abstract
Perfusion imaging allows the blood flow to the tissue
to be imaged.  It is currently widely applied to the
management of acute ischaemic stroke.  Using either
Computerised Tomography or Magnetic Resonance
Imaging techniques, perfusion maps can be created in a
short enough time to allow their routine use in clinical
practice.  Perfusion Imaging enables the physician to
directly estimate the tissue at risk which can be salvaged
with reperfusion, enabling appropriate patient selection.
Perfusion imaging however has its limitations which need
to be kept in mind when these studies are interpreted.
Although perfusion imaging is widely used, the evidence to
support its routine use in acute stroke is somewhat sparse
and therefore there are no clear cut guidelines as to its role
in this context.  The work in progress using permeability
mapping and molecular imaging techniques will further
augment the place of these techniques in the overall
management of acute stroke.  There are very few centres in
Pakistan offering routine perfusion imaging prior to
thrombolysis.
Introduction
Although blood flow to the brain was first imaged
using angiographic techniques over 60 years ago it was not
possible to accurately measure in vivo brain perfusion until
the development of radionuclide techniques in the late
1960s.1 Clinical applications of brain perfusion imaging
using radio labelled albumin macroaggregates appeared
soon afterwards2 but its application in the setting of acute
cerebral ischaemia was impractical.  The development of
first Magnetic Resonance (MR) and later Computerised
Tomographic (CT) techniques to measure brain perfusion
has brought this modality to every day clinical
applications.3,4 The technology has now evolved to the
extent that these examinations can be completed in a very
short time enabling their use in routine stroke imaging.5,6
The role of perfusion imaging in stroke
Perfusion imaging has been applied to a range of
conditions,7 but it is most widely applied in the setting of
cerebral vascular disease especially acute ischaemia.  With
the publication of the the National Institute of Neurological
Disorders and Stroke recombinant Tissue Plasminogen
Activator Stroke Study [NINDS]8 and the European
Cooperative Acute Stroke Study [ECASS]9 results in 1995,
the role of imaging in stroke underwent a paradigm shift.
The emphasis shifted from confirmation of infarction and
exclusion of haemorrhage to the detection of the 'tissue at
risk' that may be rescued with restoration of circulation.
Perfusion imaging is currently the only test available in
clinical departments that can answer this question.
Imaging of cerebral infarction in the first hour after
the onset of clinical symptoms is a challenge.  On MR
imaging this is achieved by employing Diffusion Weighted
Imaging (DWI).  However DWI only shows areas that are
already irreversibly damaged.  On CT there is no equivalent
of the DWI and although the CT may be abnormal in the
first hour the signs are subtle and difficult to recognise.10 In
both instances perfusion imaging provides the information
required for effective decision making.
Perfusion Parameters in Stroke Imaging
Perfusion is defined as the amount of blood (volume)
flowing through any tissue (mass) per unit time.  It is
usually expressed as millilitres per gram per minute
(mL/Gm/min).  In the normal brain, auto regulation of the
vasculature maintains cerebral blood flow (CBF) to the grey
matter between 50-60 mL/100Gm/min.11 CBF is the
primary perfusion parameter that is studied.  When CBF
falls to approximately half of normal (35mL/100gm/min or
less), protein synthesis in neurons stops completely
however the neurons are functional and will survive if the
CBF does not fall any further.12 When the CBF falls to
approximately a third of normal (20mL/100gm/min or less)
neuronal function is lost but the neurons may still be
viable.4 This is the tissue at risk and can be salvaged if
appropriate measures to restore the CBF are instituted.
Irreversible cell death occurs when CBF falls to less than
20% of normal (10mL/100gm/min or less).13
Cerebral blood volume (CBV) is the volume of
blood per unit brain mass.  Normal CBV is 4-5 mL/100gm.
In early ischaemia with the dilatation of the capillary bed
the CBV rises slightly or is maintained at a near normal
level despite the falling CBF.  When CBV starts to fall
irreversible cell death has occurred.4
Two parameters of transit times are usually
employed depending on the exact calculation methodology
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employed. These are Mean Transit Time (MTT) and Time to
Peak (TTP).  MTT is the interval between arterial inflow
and venous outflow and TTP is the time from the beginning
of the contrast injection to the peak enhancement within a
region of interest.4 Transit times become prolonged early in
the course of the ischaemic event and increases to
immeasurable levels as the infarct progresses.
MTT/TTP are the most sensitive for acute infarct
and generally show the largest defects on perfusion maps
but have the poorest correlation to eventual infarct size.
CBV defects have the best correlation to eventual infarct
size.14 CBF defects are the most specific for acute
infarction. The methodology for calculating these
parameters is different between CT and MR perfusion
studies; there is a close correlation between the values
obtained from the two modalities.15 The data whether
obtained from CT or MR has the same clinical relevance
and may be used interchangeably in clinical decision
making. (Table 1) (Figure 1)
Although it is possible to calculate absolute values
for CBF and CBV there are methodological constraints and
these therefore in most clinical applications use relative
values comparing the 'normal' from the 'abnormal' side
based on the patient's symptoms.  These relative values are
denoted by prefixing a small case r to the abbreviations
(rCBF, rCBV).  The rCBF and rCBV accurately reflect the
absolute values and are adequate for clinical applications.16
MR Perfusion Imaging
MR Perfusion Weighted Imaging (PWI) may be
performed with or without an intravenous (iv) injection of a
gadolinium based contrast agent.  Although clinical
applications of PWI without iv contrast using a technique
called arterial spin labelling have been described,17 it is still
largely experimental and difficult to implement, especially
on intermediate or low field strength units (1.5T or less).
Contrast based PWI is the standard for clinical imaging.
Sequential acquisitions are carried out after an iv injection
and perfusion maps are generated by the software which is
now well standardised.  The operator has to identify the
input artery, usually the middle cerebral artery. This sets the
arterial input function (AIF) and sets the time ranges.  Other
than these two steps, the calculations are automated and
reproducible.  Tissue at risk is calculated by comparing the
DWI maps with the PWI maps.  DWI/PWI mismatch is the
tissue at risk or penumbra.  Usually rCBF or rCBV maps are
employed for this purpose as MTT/TTP may be abnormal
even without any infarction (Table 1).5
Not only can tissue at risk be identified with
DWI/PWI mapping, MR angiography adds another
dimension to the overall stroke imaging. It rapidly identifies
patients that will need more aggressive interventions rather
than just iv thrombolysis.
CT Perfusion Imaging
CT perfusion imaging is carried out after the
injection of iodinated contrast medium.  The same slice is
repeatedly scanned and the rate of change of attenuation is
plotted.  On conventional spiral scanners only a single slice
can be covered. On multi detector row CT (MDCT) more
slices may be covered depending on the number of rows.
The major limitation of CT perfusion imaging is that only
the latest 64+ detector row CT scanners can achieve near
complete coverage of the brain.  Most scanners only cover
Table 1.  Interpretation of perfusion data in the first three hours of stroke onset.  Adapted from Tomandl et al.6
Perfusion Finding
Pathological Condition TTP/MTT rCBF rCBV
Normal
Arterial Stenosis or occlusion with excellent compensation
Olegemic tissue that will survive
Tissue at risk
Tissue that is irreversibly damaged
Normal
Prolonged
Prolonged
Prolonged
Strong prolongation or may not be measurable
Normal
Normal
Moderately reduced
Markedly reduced
Severely reduced
Normal
Normal
Normal or slightly elevated
Normal or slightly reduced
Severely reduced
Figure 1. MR of the brain with diffusion and perfusion images demonstrating the ischemic
penumbra. A 60-year-old male with acute onset of left-sided hemiparesis for 30 minutes. A: T2-
weighted axial image is within normal limits. B: Coronal FLAIR images also within normal
limits. C: b1000 Diffusion-weighted image shows no significant diffusion restriction. D: CBF
map showing asymmetry with reduced blood flow in the right temporal and parietal lobes. E:
CBV map showing asymmetry with some increased CBV in the corresponding area. F: MTT map
demonstrating marked prolongation of MTT. Findings are those of impending infarction with no
restriction of diffusion, reduced blood flow, or preserved blood.  [From Hussain Z et al (7)]
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1 to 4, 10mm slices of the brain and therefore substantial
perfusion defects may be missed unless multiple boluses are
used.18 The operator sets regions of interest over the input
artery and the draining vein.  The rest of the calculations are
usually automated.5
As there is no DWI equivalent in CT scanning the
tissue at risk is calculated by rCBV/rCBF mismatch, as
CBV has the closest correlation to DWI abnormalities.15
Like MR imaging it is now possible to have a 'one stop'
imaging with CT scanning with the one scan providing
anatomic, perfusion as well as angiographic information.19
CT or MR?
The comparative merits and disadvantages of CT
and MR are listed in Table 2.  As far as the clinical
applicability of the perfusion parameters is concerned there
is not much to choose between them.15 The choice therefore
is based on local availability and logistics. Due to the wide
availability of CT and its high sensitivity to the presence of
haemorrhage, most patients being considered for
thrombolysis will have a CT first.  If an angiogram and a
perfusion image can be obtained in an additional 10 minutes
without moving the patient it would be the ideal scenario.6
Limitations of Perfusion Imaging
Some of the limitations such as the limited coverage
on CT perfusion have already been discussed earlier in the
article.
The major limitation of MR perfusion imaging is
related to the arterial input function (see above).  As the
acquisitions are dependent on a T2* signal drop it may not
be possible to visually confirm the adequacy of the injection
and therefore it is mandatory to plot a time activity curve to
confirm that the bolus profile was satisfactory.  Dispersion
of the bolus leads to clinically significant errors in the
calculation of CBF.20 CBV calculations may be more
robust.  Although relative values (rCBV, rCBF) may be less
prone to bolus dispersion, as they depend on a comparison,
if the two sides have symmetrical defects the maps will be
erroneously normal. This is also true if the injection is either
erroneously timed (or not given at all) so that the acquisition
is completed before the bolus arrives.
Current Recommendations for the Use of
Perfusion Imaging in Stroke
Although many studies have demonstrated that
perfusion imaging provides additional information,
systematic reviews of the published literature have failed to
determine its exact role in either diagnosis or treatment
stratification in acute stroke.21,22 There is no universal
agreement as to the sensitivity or specificity of the
mismatch or its role in selecting patients for thrombolysis.
In view of these facts there are no clear cut
recommendations.  Common sense would suggest that
while more data is accumulated patients should benefit from
the additional information if it can be obtained within a
reasonable length of time so that treatment is not delayed.
The Future
The stage is set for the next paradigm shift in
imaging.  MR permeability studies looking at the integrity
of the blood brain barrier are already undergoing clinical
trials.23 The early data suggests that disruption of the blood
brain barrier may be a helpful sign in predicting
haemorrhage in acute stroke.24 Developments in molecular
imaging are targeting the molecular cascade in the
development and evolution of the penumbra. New
developments as well as better data to support the already
established technologies is likely to have a significant
impact leading to improvements in outcomes for stroke
Table 2. Comparison of CT and MR imaging for the evaluation of acute stroke. Adapted from Sirinavasan et al. 5
Characteristic CT MR Imaging
Availability
Examination time
Imaging Volume for perfusion study
Ability to exclude haemorrhage
Ability to detect early irreversible infarction
Risks to patient
Good, getting much better
5-10 minutes
2-4 cms
Excellent
Good (needs perfusion mapping)
Fair, Getting better
15-30 minutes
Entire Brain
Good but may require expert interpretation
Excellent (using DWI)
Radiation Ionising radiation and associated risks No Radiation
Contrast Agent Iodinated contrast mandatory, risks of allergic and
toxic effects
May not be required if canner able to perform spin
labelled imaging.  Gadolinium based contrast has
significantly lower allergic and toxic effects at the
doses administered.
Environment No special risks, easy to monitor patient, no
absolute contraindications
Magnetic fields, restricted access, difficult to
monitor patient, absolute contraindications
(pacemakers)
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sufferers.
Situation in Pakistan
Although the availability of MR and CT units
capable of carrying out state of art stroke imaging is
growing, very few of these are in acute hospitals where
acute neurological emergencies are handled. As an example
in Karachi, of over 20 centres with either a MR or a CT
scanner only 2 units offer routine perfusion imaging.  There
has to be a serious rethink of the health care strategies to
make healthcare more accessible and relevant for the people
of Pakistan.25
Summary
Perfusion imaging adds additional important
information in the setting of acute ischaemic stroke.  It may
be obtained by several means.  In clinical practice it is
obtained either by MR or CT after the administration of iv
contrast.  It helps define the tissue at risk and may be helpful
in appropriate selection of patients suitable for
thrombolysis.  Both of the most widely applied techniques
(CT and MR) have their limitations and pitfalls which need
to be considered when interpreting the images.
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